产物药物及其激活机制用于向大脑输送药物
Ida Aaberg Lillethorup1, Andreas Victor Hemmingsen1, Katrine Qvortrup1
1Department of Chemistry, Technical University of Denmark 2800 Kongens Lyngby Denmark kaqvo@kemi.dtu.dk.
RSC medicinal chemistry
|January 20, 2025
概括
代理药物增强了通过大脑屏障的药物输送. 本综述详细介绍了自2000年以来开发的新型中枢神经系统前药物激活机制,以改善大脑药物向.
科学领域:
- 药理学和药物输送 药理学和药物输送
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 产物药物是活性化在体内的非活性药物前体.
- 它们改善了药物的特性,如溶解性和向性.
- 大脑屏障限制了药物进入,需要特殊的策略,如前药物.
研究的目的:
- 审查中枢神经系统 (CNS) 中的前药激活机制.
- 突出了自2000年以来为中枢神经系统前药物激活开发的工具.
- 解决有关大脑特异性前药物激活的文献上的差距.
主要方法:
- 自2000年以来的科学出版物的文献评论.
- 专注于旨在针对大脑和中枢神经系统激活的前药物.
- 基于化学或生物触发器的激活机制的分类.
主要成果:
- 确定各种适合中枢神经系统环境的前药激活策略.
- 对前期药物的创新化学和酶方法的讨论.
- 对超越大脑障碍的前药物设计方面的进展进行分析.
结论:
- 有效的中枢神经系统前药物激活对于大脑药物开发至关重要.
- 最近的创新提供了有前途的工具,用于针对性地向大脑输送药物.
- 对中枢神经系统前药物激活机制的进一步研究将促进神经治疗.
相关概念视频
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
Drug Delivery: Parenteral Route
397
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
397
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Drugs Affecting Neurotransmitter Release or Uptake
931
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
931
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K


